Bio & Insurance Information

Dr. Sravana Chennupati is a radiation oncologist that currently lives and practices in Berkeley, California. He is certified by the American Board in radiation oncology and works at the moment at three medical institutions, OHSU Hospital, Alta Bates Summit Medical Center and Diablo Valley Oncology and Hematology Medical Group. Dr. Chennupati received his medical degree from Stanford University School of Medicine and has over 10 years of experience in the radiation oncology field. After he got his medical degree Dr. Chennupati went to Kaiser Permanente Medical Group and completed an internship in internal medicine. He finished his medical studies with a residency in radiation oncology at Oregon Health & Science University. Dr. Chennupati accepts the following insurances: Aetna, Cigna, MultiPlan, Blue Shield of California, Blue Cross of California, FirstHealth PPO.



Education & Training

Stanford University School of Medicine

Medical School

Kaiser Permanente Medical Group

Internship

Oregon Health & Science University

Residency

Board Certifications

American Board of Radiology - Diagnostic Radiology

Hospitals & Clinics

Alta Bates Summit Medical Center - Herrick Campus

Languages: English/Spanish

(510) 204-1591

2001 Dwight Way

Berkeley, California 94704

Read More

Diablo Valley Oncology and Hematology Medical Group

Languages: English/Spanish

(925) 677-5041

400 Taylor Blvd #202

Pleasant Hill, California 94523

Read More

OHSU Hospital - Portland

Languages: English/Spanish

(503) 494-8311

3181 SW Sam Jackson Park Rd

Portland, Oregon 97239

Read More

Publications

Dr. Sravana K. Chennupati has contributed to 3 publications.

The impact of hormonal therapy on sexual quality of life in men receiving intensity modulated radiation therapy for prostate cancer.

Son, C. H.,Chennupati, S. K.,Kunnavakkam, R.,Liauw, S. L.; Pract Radiat Oncol. 2014 Dec 11.

See more >>

Late toxicity and quality of life after definitive treatment of prostate cancer: redefining optimal rectal sparing constraints for intensity-modulated radiation therapy.

Chennupati, S. K.,Pelizzari, C. A.,Kunnavakkam, R.,Liauw, S. L.; Cancer Med. 2014 May 08.

See more >>

Positron emission tomography for predicting pathologic response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer.

Chennupati, S. K.,Quon, A.,Kamaya, A.,Pai, R. K.,La, T.,Krakow, T. E.,Graves, E.,Koong, A. C.,Chang, D. T.; Am. J. Clin. Oncol.. 2011 Mar 23.

See more >>